Hint mode is switched on Switch off
For swift navigation between sections

Stevanato Group

PDF download

Choose all Reset all
Download Cancel
Organization name
Stevanato Group S.p.A.
Country name
Italy
Country of registration
-
Industry
Packaging
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Stevanato Group S.p.A. is an italian multinational company active in the glass tube forming technology and inspection systems sector. The Group is the first worldwide producer of insulin cartridges for diabetes treatment and design and production of machinery for glass tubing converting.

Awards

News

07/05/2026 Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
06/03/2026 Stevanato Group S.p.A. (NYSE:STVN) Overview and Financial Performance
06/03/2026 Stevanato Group S.p.A. (NYSE:STVN) Stock Update and Market Outlook
04/03/2026 Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
19/02/2026 Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • CIK
    0001849853
Registration is required to get access.